Search Results - "Blomster, Timo"

Pregnancy period and early-life risk factors for inflammatory bowel disease: a Northern Finland birth cohort 1966 study by Blomster, Timo M, Koivurova, Olli-Pekka, Koskela, Ritva, Herzig, Karl-Heinz, Talley, Nicholas J, Ronkainen, Jukka

“…The pathogenesis of inflammatory bowel disease (IBD) has not been fully elucidated. The aim of this study was to analyze the pregnancy period, perinatal…”
Get full text

Real-life treatment persistence and treatment outcomes of Finnish patients with inflammatory bowel disease receiving vedolizumab as first-line biological treatment by Ylisaukko-oja, Tero, af Björkesten, Clas-Göran, Eberl, Anja, Nuutinen, Heikki, Jussila, Airi, Molander, Pauliina, Koskela, Ritva, Blomster, Timo, Pajala, Markku, Ilus, Tuire, Haiko, Paula, Kovac, Bianca, Silvola, Saija, Smith, Sarah, Jokelainen, Jari, Sipponen, Taina

“…To analyze treatment persistence and treatment outcomes of vedolizumab as first-line biological treatment in Crohn's disease (CD) and ulcerative colitis (UC)…”
Get full text

Su1084: EXTRAINTESTINAL MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE ARE COMMON IN A HIGH PREVALENCE REGION, A NORTHERN FINLAND BIRTH COHORT 1966 STUDY by Blomster, Timo, Talley, Nicholas J., Ronkainen, Jukka

Get full text

Long-term outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNFα-blocking agents by Molander, Pauliina, Färkkilä, Martti, Kemppainen, Helena, Blomster, Timo, Jussila, Airi, Mustonen, Harri, Sipponen, Taina

“…Background: Little data exist on the long-term prognosis of patients with inflammatory bowel disease (IBD) after stopping TNFα-blocking therapy in deep…”
Get full text

Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission? by Molander, Pauliina, Färkkilä, Martti, Ristimäki, Ari, Salminen, Kimmo, Kemppainen, Helena, Blomster, Timo, Koskela, Ritva, Jussila, Airi, Rautiainen, Henna, Nissinen, Markku, Haapamäki, Johanna, Arkkila, Perttu, Nieminen, Urpo, Kuisma, Juha, Punkkinen, Jari, Kolho, Kaija-Leena, Mustonen, Harri, Sipponen, Taina

“…This prospective multicenter study examined whether elevated fecal calprotectin (FC) concentrations after stopping TNFα-blocking therapy can predict clinical…”
Get full text

Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and Helicobacter pylori Infection in Gastroscopy Referral Patients: Clinical Validation of the New-Generation GastroPanel ® Test by KOIVUROVA, OLLI-PEKKA, KOSKELA, RITVA, BLOMSTER, TIMO, ALA-RÄMI, ANTTI, LUMME, HENRI, KETTUNEN, OLLI, HUKKANEN, JANNE, KARTTUNEN, TUOMO J., MÄKINEN, MARKUS, RONKAINEN, JUKKA, SYRJÄNEN, KARI

“…Background/Aim: Prompted by the increasing demand of non-invasive diagnostic tools for screening of gastric cancer (GC) risk conditions, i.e., atrophic…”
Get full text

Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD by Molander, Pauliina, Sipponen, Taina, Kemppainen, Helena, Jussila, Airi, Blomster, Timo, Koskela, Ritva, Nissinen, Markku, Rautiainen, Henna, Kuisma, Juha, Kolho, Kaija-Leena, Färkkilä, Martti

“…Deep remission, meaning clinical remission with mucosal healing (MH), with anti-tumor necrosis factor-alpha (TNF-α) agents is a new target for therapy in…”
Get full text

Outcome after discontinuation of TNFα-blocking therapy in patients with inflammatory bowel disease in deep remission by Molander, Pauliina, Färkkilä, Martti, Salminen, Kimmo, Kemppainen, Helena, Blomster, Timo, Koskela, Ritva, Jussila, Airi, Rautiainen, Henna, Nissinen, Markku, Haapamäki, Johanna, Arkkila, Perttu, Nieminen, Urpo, Kuisma, Juha, Punkkinen, Jari, Kolho, Kaija-Leena, Mustonen, Harri, Sipponen, Taina

“…Few data are available on the disease course in patients with inflammatory bowel disease (IBD) in deep remission after discontinuing tumor necrosis factor α…”
Get full text

56 - Oral Iron Supplementation During First Year of Life and Diphteria, Tetanus, Pertussis and Polio Vaccination Reduce the Risk of Inflammatory Bowel Disease by Blomster, Timo, Koivurova, Olli-Pekka, Koskela, Ritva, Herzig, Karl-Heinz, Koiranen, Markku, Talley, Nicholas J., Ronkainen, Jukka

Get full text

High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab - a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO) by Ylisaukko-oja, Tero, Aaltonen, Jaakko, Nuutinen, Heikki, Blomster, Timo, Jussila, Airi, Pajala, Markku, Salminen, Kimmo, Moilanen, Veikko, Hakala, Kalle, Kellokumpu, Mikko, Toljamo, Kari, Rautiainen, Henna, Kuisma, Juha, Peräaho, Markku, Molander, Pauliina, Silvennoinen, Jouni, Liukkonen, Ville, Henricson, Hans, Tillonen, Jyrki, Esterinen, Mirva, Nielsen, Christian, Hirsi, Eija, Lääne, Margus, Suhonen, Ulla-Maija, Vihriälä, Ilkka, Mäkelä, Petri, Puhto, Mika, Punkkinen, Jari, Sulonen, Hannu, Herrala, Sauli, Jokelainen, Jari, Tamminen, Klaus, Sipponen, Taina

“…Objectives: The efficacy and tolerability of vedolizumab in the treatment of inflammatory bowel diseases (IBD) has been demonstrated in an extensive GEMINI…”
Get full text

Sa1934 - Evaluation of Treatment Persistence of Vedolizumab among Finnish Inflammatory Bowel Disease (IBD) Patients in Real-Life Clinical Practice (FINVEDO) by Ylisaukko-Oja, Tero, Eberl, Anja, Aaltonen, Jaakko, Nuutinen, Heikki, Blomster, Timo, Jussila, Airi, Pajala, Markku, Jokelainen, Jari, Herrala, Sauli, Tamminen, Klaus, Sipponen, Taina

Get full text

Evaluation of Treatment Persistence of Vedolizumab among Finnish Inflammatory Bowel Disease (IBD) Patients in Real-Life Clinical Practice (FINVEDO) by Ylisaukko-Oja, Tero, Eberl, Anja, Aaltonen, Jaakko, Nuutinen, Heikki, Blomster, Timo, Jussila, Airi, Pajala, Markku, Jokelainen, Jari, Herrala, Sauli, Tamminen, Klaus, Sipponen, Taina

Get full text

Su1064 Pain Hypersensitivity Among Women With Gastroesophageal Reflux Disease Is Explained by Psychological Distress by Koivurova, Olli-Pekka, Blomster, Timo, Auvinen, Juha, Herrala, Sauli, Karppinen, Jaro, Talley, Nicholas J, Ronkainen, Jukka

Get full text

Mo2043 Increased Pain Hypersensitivity in Women With Irritable Bowel Syndrome and Functional Dyspepsia Explained by Psychological Factors: A Prospective Birth Cohort Population by Koivurova, Olli-Pekka, Blomster, Timo, Auvinen, Juha, Herrala, Sauli, Karppinen, Jaro, Talley, Nicholas J, Ronkainen, Jukka

Get full text

Characterization of inflammatory bowel disease management by vedolizumab and concomitant treatments in real-life clinical practice by Ylisaukko-oja, Tero, Torvinen, Saku, Aaltonen, Jaakko, Nuutinen, Heikki, Blomster, Timo, Jussila, Airi, Pajala, Markku, Salminen, Kimmo, Moilanen, Veikko, Hakala, Kalle, Kellokumpu, Mikko, Toljamo, Kari, Rautiainen, Henna, Kuisma, Juha, Peräaho, Markku, Molander, Pauliina, Silvennoinen, Jouni, Liukkonen, Ville, Henricson, Hans, Tillonen, Jyrki, Esterinen, Mirva, Nielsen, Christian, Hirsi, Eija, Lääne, Margus, Suhonen, Ulla-Maija, Vihriälä, Ilkka, Mäkelä, Petri, Puhto, Mika, Punkkinen, Jari, Sulonen, Hannu, Herrala, Sauli, Jokelainen, Jari, Tamminen, Klaus, Sipponen, Taina

“…Limited data is available on vedolizumab combination therapies in real-world clinical practice. Here, we evaluated the concomitant corticosteroid,…”
Get full text

1054 Elevated Fecal Calprotectin Predicts Relapse in Inflammatory Bowel Disease Patients After Stopping TNFα-Blocking Agents by Molander, Pauliina, Färkkilä, Martti A, Ristimäki, Ari, Salminen, Kimmo, Kemppainen, Helena, Blomster, Timo, Koskela, Ritva, Jussila, Airi, Rautiainen, Henna, Nissinen, Markku, Haapamäki, Johanna, Arkkila, Perttu E, Nieminen, Urpo, Kuisma, Juha, Punkkinen, Jari, Kolho, Kaija-Leena, Mustonen, Harri, Sipponen, Taina

Get full text

A domestic human case of hepatitis E in Finland by Kettunen, Olli, Vuorela, Marjo, Kuusi, Markku, Kantala, Tuija, Maunula, Leena, Jalava, Katri, Blomster, Timo, Koskela, Ritva, Haapasaari, Kirsi-Maria

“…We describe the first verified domestic HEV case in a previously healthy 53-year-old man who presented a three-day history of upper stomach pain, nausea,…”
Get full text